WillItSurvive
Insurance technology companies · Brazil

Sami

sami.com.br ↗

Brazilian digital-first health insurer covering about 18,000 members with AI-driven cost control.

Losing its protection
Assessed 23 July 2026 · Evidence as of 23 July 2026
The structural protection is eroding.
On the recordSince 23 July 2026 · Checkable from H2 2026 · Every call on the record Checkpoint: Confirmation of 2024 break-even and any new funding round
The call

Sami has the license and the loyalty to survive, but its silence on funding and scale gap against Amil and Hapvida leave its next twelve months genuinely uncertain.

Sami sells health insurance in Brazil using technology to keep costs down, and its customers give it very high ratings (89 out of 100). The company is profitable or nearly profitable, but it has only 18,000 members while its biggest rival Amil has over 3 million, making Sami roughly 170 times smaller. Because Brazil's government tightly controls who can run a health insurer, new startups cannot easily enter the market, which protects Sami, but the bigger insurers like Amil and Hapvida are not blocked from copying Sami's technology and approach, they just move slower and may now be trying harder after a major money injection. The key question is whether Sami can grow and stay independent without new funding, or whether it will run out of money or get bought by a larger player.

Why
01
AI pressure: None apparent. AI tools generate 100% of Sami's patient summaries in-house, cutting costs rather than threatening the business. Could AI do the core job? Unlikely.
02
Bigger players: Amil (post Advent/Bain recapitalization) and Hapvida/Notredame Intermédica. Amil's 2026 PE-backed recapitalization and Hapvida's vertical integration could fund a digital SME product that copies Sami at 100x its scale. Could a giant copy it? Yes, easily.
03
What protects it. An ANS insurance license plus real member trust (NPS 89) that new entrants and copycats can't get overnight.
What would change this call
Sami announces a Series C or later funding round in the next 6-12 months. Would show investor confidence and continued capital access despite no funding since May 2023.
Sami publicly confirms 2024 profitability or break-even results. Would show the company reached self-sustaining economics rather than facing runway stress.
Amil or Hapvida/Notredame Intermédica launches a digital-direct SME health plan. Would show incumbents copying Sami's model at scale, eroding its differentiation.
Key numbers
  • 18,000+ members vs Amil's 3.1M (2023)
  • $18M Series B raised (May 2023)
  • No funding announced since mid-2023 (2026)
Named risks
  • No disclosed funding round since May 2023 Series B raises cash-runway uncertainty. Severity: high
  • Unconfirmed 2024 break-even target leaves profitability status unresolved publicly. Severity: high
  • Sector consolidation: Amil PE recapitalization or IPO could fund an aggressive digital-direct SME product. Severity: medium
  • ANS regulatory changes to provisioning or pricing rules could disproportionately affect small digital-native operators. Severity: medium
  • Incumbents already hold ANS licenses and could copy Sami's digital-care model at far greater scale. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
Amillosing toAmil has 3.1M members and R$31.7B revenue in 2025 vs Sami's ~18k-27k members in 2023
Amilgaining onAmil reportedly gaining share from Hapvida/Intermedica in Sao Paulo as of July 2026
Hapvida/Notredame Intermedicalosing toVertically integrated incumbent at massive scale versus Sami's subscale digital model, 2023-2026
Alice (Alice Saude)contestingComparable Brazilian VC-backed digital-first insurtech peer, vendor-cited comparison, 2025
SulAmerica/Bradesco SaudecontestingNamed as traditional incumbent competitors in vendor-authored competitive landscape, 2025-07-11
Questions people ask
Is Sami profitable in 2026?
Not confirmed. As of the 2023 Series B, Sami reported a 30% margin on premiums written but was not yet profitable, with a break-even target set for 2024. No public data confirms whether that break-even was reached by 2026.
Who owns Sami, the Brazilian health insurance startup?
Sami is privately held and founder-led by CEO Guilherme Berardo and President Dr. Vitor Asseituno, who co-founded it in 2018. Investors include Redpoint eventures, Mundi Ventures, Valor Capital Group and Endeavor Catalyst from its 2023 Series B round.
How much funding has Sami raised?
Sami raised roughly $349K in a March 2019 seed round, R$110M (~$21M) in a 2021 Series A led by Valor Capital Group, and $18M in a May/June 2023 Series B led by Redpoint eventures and Mundi Ventures, with no new round disclosed through mid-2026.
Could AI replace Sami's health insurance business?
No. Sami uses AI internally as a cost lever, with 100% of patient summaries AI-generated (81% approved unedited) and CI&T generative AI saving about 900 hours per month in care coordination as of June 2024, but its ANS insurance license and provider network are the real product, not something AI replaces.
Who is Sami's biggest competitor?
Amil is Sami's largest incumbent threat, with 3.1 million medical-plan members and R$31.7B revenue in 2025 versus Sami's roughly 18,000 to 27,000 members in 2023. Amil was in stake-sale talks with Advent and Bain as of July 2026.
How many members does Sami health insurance have?
Sami reported more than 18,000 active members as of its June 2023 Series B announcement, with a target of 27,000 by end of 2023, up from roughly 10,000 members in 2022, per company statements.
Timeline
  • 2026-07-01Amil in active stake-sale talks with PE firms Advent and Bain, considering IPO
  • 2024-06-23CI&T case study reports Sami generative AI saved ~900 hours/month in care coordination
  • 2024-02-09UnitedHealth completes sale of Amil to Jose Seripieri Filho for ~R$11B
  • 2023-09-24Sami Series B reported at below $500M post-money valuation, not yet profitable
  • 2023-06-01Sami closes $18M Series B led by Redpoint eventures and Mundi Ventures
  • 2022Sami reports ~10,000 members, 75% first-time private insurance buyers
  • 2021Sami closes R$110M (~$21M) Series A led by Valor Capital Group
  • 2019-03Sami raises ~$349K seed round
  • 2018Sami founded by Guilherme Berardo and Dr. Vitor Asseituno
Revision history
23 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
PineappleQoalaRenewBuy
More in Insurance technology companies →
Sources